For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Parekawhia McLean: Meet the Māori monitor setting a ‘fearless’ agenda
Parekawhia McLean: Meet the Māori monitor setting a ‘fearless’ agenda

In a year where the Coalition Government has acted on promises to disband Te Aka Whai Ora Māori Health Authority, remove equity as a health priority and discourage official use of te reo Government agency names, the yet-to-be proven iwi Māori partnership boards can appear like the last man standing from the Pae Ora (Healthy Futures) legalisation for those seeking meaningful input from Māori into Māori health policy and service provision. But there is another; the Hauora Māori Advisory Committee. Reporter Alan Perrott talks to the committee leader seeking a greater voice in the delivery of equity and Māori healthcare
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.